Category: Patient Care

About NETRF

The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.

Blog

Exercise and Cancer

[breakout] Talk to your doctor before changing your activity level. You may need to make important modifications based on medication you are taking, surgery you

Read More »
Blog

Finding Inspiration in Being Rare

A Journey in Advocacy Greta Stifel isn’t just “rare,” she’s triple “rare.” After being diagnosed with Carcinoid Cancer, she simultaneously developed Carcinoid Syndrome, and recently

Read More »
Blog

First PRRT Approved by U.S. FDA

New treatment for GI and pancreatic NETs The U.S. Food and Drug Administration (FDA) has approved Peptide Receptor Radionuclide Therapy (PRRT) with a new radiopharmaceutical for

Read More »
Blog

Let’s Talk About Lung NETs

Neuroendocrine tumors (NETs) are less common than other types of lung cancer but recognized with increased frequency due to advances in imaging technology and the

Read More »
Blog

PRRT for Pancreatic NETs

NETRF in collaboration with NANETS awarded the 2017 Basic Translational Science Investigator grant to Brian R. Untch, M.D., at Memorial Sloan Kettering Cancer Center for his proposal, “Enhancing Peptide Receptor Radionuclide Therapy in Well-Differentiated Pancreatic Neuroendocrine Tumors.”

Read More »
Blog

CAR T-Cell Therapy Earns Another FDA Approval

He is a pioneer whose work has helped extend the horizon of cancer care, creating a new category of individualized immunotherapy. Carl June, MD, has conducted 25 years of scientific research to advance CAR T-cell therapy. And all that knowledge is now helping to tackle NETs.

Read More »